Eleni Efstathiou

21.8k citations

203 papers · 7.4k indexed · 4 hit papers · h-index 41

Impact in

Pulmonary and Respiratory Medicine top 0.2%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Cancer Research top 0.5%
- Cancer, Lipids, and Metabolism

Papers in

Pulmonary and Respiratory Medicine 149
- Prostate Cancer Treatment and Research 137
- Prostate Cancer Diagnosis and Treatment 29
Cancer Research 53
- Cancer, Lipids, and Metabolism 34

Co-authors: Christopher J. Logothetis Meletios Α. Dimopoulos Patricia Troncoso Charles L. Sawyers Sumit K. Subudhi Anh Hoang Howard I. Scher Vassiliki Tzelepi
Journals: Journal of Clinical Oncology (70 papers)Annals of Oncology (11 papers)European Urology (9 papers)Clinical Cancer Research (8 papers)Cancer Research (7 papers)
Partner nations: United States Greece Canada

In The Last Decade

Eleni Efstathiou

189 papers receiving 7.3k citations

Hit Papers

align trajectories log scale

Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer 2020 · 266 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 New England Journal of Medicine
2017 Nature Medicine
2013 Cell
2010 The Lancet

Peers

Countries citing papers authored by Eleni Efstathiou

Since Specialization

Citations

This map shows the geographic impact of Eleni Efstathiou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleni Efstathiou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleni Efstathiou more than expected).

Fields of papers citing papers by Eleni Efstathiou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleni Efstathiou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleni Efstathiou. The network helps show where Eleni Efstathiou may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Eleni Efstathiou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eleni Efstathiou Line = papers co-authored together Eleni Efstathiou links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Barriers and solutions for healthcare professionals to involve patients as partners in oncology research: Project RISE Future Oncology ·Eamonn Rogers, Ida Bagus Putu Purbadhamaja, 潤水上, Cynthia Claudia Romero, Irene Broer, Jan Geißler, Avril Pyman, Patricia Sierra Casas, Laura Dormer, Jacqueline S. Daly, Jessica M. Scott, Eleni Efstathiou	2025	0
2	Patient-reported Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1/2 Gene Alterations: Final Analysis from the Randomized Phase 3 MAGNITUDE Trial European Urology ·Dana E. Rathkopf, Guilhem Roubaud, Kim N., Eleni Efstathiou, Gerhardt Attard, David Olmos, Eric J. Small, Marniza Saad, Elena Castro, Won Kim, Daphne Wu, Zagrekov Ia, Shiva Dibaj, Jenny Zhang, Peter Francis, Matthew R. Smith	2024	5
3	The Role of Dynamic Contrast Enhanced Magnetic Resonance Imaging in Evaluating Prostate Adenocarcinoma: A Partially‐Blinded Retrospective Study of a Prostatectomy Patient Cohort With Whole Gland Histopathology Correlation and Application of PI‐RADS or TNM Staging The Prostate ·J. F. French, Michel Onfray, Ion Codreanu, Nakul Gupta, Shu Zhang, Eleni Efstathiou, M. -Z. Wang, Steven S. Shen, Peter S. LaViolette, Brian J. Miles, Diego R. Martín	2024	1
4	The role of Cabazitaxel in Patients With Castration-Resistant and Osseous Metastases Prostate Cancer. A Hellenic Cooperative Oncology Group Phase II Study Clinical Genitourinary Cancer ·Michalis Liontos, Anna Goussia, Nikolaos Korfiatis, Karl‐Heinz Reps, Robin George, A. Visvikis, Georgios Petrakis, Marinos Tsiatas, Elena Fountzilas, Epaminontas Samantas, George Fountzilas, Eleni Efstathiou	2024	1
5	LBA85 Niraparib (NIRA) with abiraterone acetate plus prednisone (AAP) as first-line (1L) therapy in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations: Three-year update and final analysis (FA) of MAGNITUDE Annals of Oncology ·Emma Billmyer, Elena Castro, Gerhardt Attard, Matthew R. Smith, Shahneen Sandhu, Eleni Efstathiou, Guilhem Roubaud, Eric J. Small, S.V. FEDOSOV, Dana E. Rathkopf, Marniza Saad, Howard Gurney, Wonho Jung, Gary Mason, Shiva Dibaj, Daphne Wu, B. Diorio, Angela Lopez‐Gitlitz, Sook-An Jeoung, David Olmos	2023	6
6	The biology behind combining poly [ADP ribose] polymerase and androgen receptor inhibition for metastatic castration-resistant prostate cancer European Journal of Cancer ·Neeraj Agarwal, Tian Zhang, Eleni Efstathiou, Nicolas Sayegh, Arne Engelsberg, Fred Saad, Karim Fizazi	2023	21
7	Chemotherapy, immunotherapy, or combination first-line treatment for metastatic urothelial carcinoma of the bladder: A large real-world experience. Journal of Clinical Oncology ·William Conley, Carlos Riveros, Niccolò Rivetti, 琼华伍, Jesica Tatiana Mojica Cruz, Łukasz Grzyb, N. P. Baudat, Jun Zhang, Eleni Efstathiou, Christopher J.D. Wallis, Guru Sonpavde, Raj Satkunasivam	2023	1
8	1806P Efficacy of niraparib and abiraterone acetate plus prednisone (NIRA+AAP) in homologous recombination repair gene-altered (HRR+) metastatic castration-resistant prostate cancer (mCRPC) by tissue and/or plasma assays in the MAGNITUDE trial Annals of Oncology ·G. Attard, Shahneen Sandhu, Dana E. Rathkopf, Elena Castro, Marniza Saad, Mitchell R. Smith, Eric J. Small, David Olmos, S.V. FEDOSOV, Guilhem Roubaud, Bogdan Żurawski, Eleni Efstathiou, Daphne Wu, B. Diorio, Karen Urtishak, Umesh Singh, Yan Xu, Angela Lopez‐Gitlitz, MT Gomez Sánchez, K.N. Chi	2023	2
9	Consistent survival benefit of enzalutamide plus androgen deprivation therapy in men with nonmetastatic castration-resistant prostate cancer: PROSPER subgroup analysis by age and region European Journal of Cancer ·Ugo De Giorgi, Maha Hussain, Neal D. Shore, Karim Fizazi, Bertrand Tombal, David F. Penson, Fred Saad, Eleni Efstathiou, Katarzyna Madziarska, Joyce Steinberg, Jennifer Sugg, Xun Lin, Qi Shen, Cora N. Sternberg	2021	8
10	Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer European Journal of Cancer ·P. Lau, Rainer Wahl, Koh Kai Bing, John W. Davis, Amado J. Zurita, Xuemei Wang, Shi‐Ming Tu, Brian F. Chapin, Ana M. Aparicio, Paul G. Corn, Jennifer Wang, Sumit K. Subudhi, John C. Araujo, John Papadopoulos, NADIA MICALI, خسرو حسینیپژوه, Christopher J. Logothetis, Eleni Efstathiou	2021	12
11	A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer Clinical Genitourinary Cancer ·P. Lau, Rainer Wahl, خسرو حسینیپژوه, Alexandros Tsikkinis, Anh Hoang, Ana M. Aparicio, Shi‐Ming Tu, John C. Araujo, Amado J. Zurita, Paul G. Corn, Lance C. Pagliaro, Jeri Kim, Jennifer Wang, Sumit K. Subudhi, Nizar M. Tannir, Christopher J. Logothetis, Patricia Troncoso, Xuemei Wang, Sijin Wen, Eleni Efstathiou	2020	13
12	B7-H3 Expression in Merkel Cell Carcinoma–Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density Clinical Cancer Research ·Phyu P. Aung, Edwin R. Parra, Souptik Barua, Dawen Sui, Jing Ning, Barbara Mino, Tuosu Dai, Jonathan L. Curry, Priyadharsini Nagarajan, Carlos A. Torres‐Cabala, Eleni Efstathiou, Anh Hoang, Michael K. Wong, Jennifer A. Wargo, Alexander J. Lazar, Arvind Rao, Víctor G. Prieto, Ignacio I. Wistuba, Michael T. Tetzlaff	2019	29
13	Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer Clinical Cancer Research ·Andreas Varkaris, Paul G. Corn, Nila U. Parikh, Eleni Efstathiou, Jian H. Song, Yu-Chen Lee, Ana M. Aparicio, Anh Hoang, Sanchaika Gaur, M Krishnan Nair, Sankar N. Maity, Stoeva Velena, Bogdan Czerniak, Yiping Shao, Mian M. Alauddin, Sue-Hwa Lin, Christopher J. Logothetis, Gary E. Gallick	2015	37
14	Activation of β-Catenin Signaling in Androgen Receptor–Negative Prostate Cancer Cells Clinical Cancer Research ·Xinhai Wan, Jie Liu, Rugang DUAN, Vassiliki Tzelepi, Jun Yang, Michael W. Starbuck, Lixia Diao, Jing Wang, Eleni Efstathiou, Elba S. Vázquez, Patricia Troncoso, Sankar N. Maity, Nora M. Navone	2012	61
15	Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC‐0449 in the bone forming prostate cancer xenograft MDA PCa 118b The Prostate ·Μαρία Κάρλου, Jing‐Fang Lu, Guanglin Wu, Sankar N. Maity, Vassiliki Tzelepi, Nora M. Navone, Anh Hoang, Christopher J. Logothetis, Eleni Efstathiou	2012	26
16	Modeling a Lethal Prostate Cancer Variant with Small-Cell Carcinoma Features Clinical Cancer Research ·Vassiliki Tzelepi, Jiexin Zhang, Rugang DUAN, Sarah Waleed Hashim, Guanglin Wu, Xinhai Wan, Anh Hoang, Eleni Efstathiou, Kanishka Sircar, Nora M. Navone, Patricia Troncoso, Shoudan Liang, Christopher J. Logothetis, Sankar N. Maity, Ana M. Aparicio	2011	105
17	Inhibition of Mxi1 suppresses HIF-2α-dependent renal cancer tumorigenesis Cancer Biology & Therapy ·Chun C. Tsao, Bin Tean Teh, Eric Jonasch, Nicola Di Rienzo, Eleni Efstathiou, Anh Hoang, M. Feldman, Christopher J. Logothetis, Paul G. Corn	2008	15
18	Androgen receptor-negative human prostate cancer cells induce osteogenesis through FGF9-mediated mechanisms Cancer Research ·Zhigang Li, Nora M. Navone, H. J. Yang, Jie Liu, Paul Mathew, Michael W. Starbuck, Amado J. Zurita, Charles R. Sikes, Asha S. Multani, Eleni Efstathiou, Adriana López, Jing Wang, Tina V. Fanning, Víctor G. Prieto, Vikas Kundra, Patricia Troncoso, Austin K. Raymond, Sue-Hwa Lin, Elba S. Vázquez	2008	10
19	The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy Annals of Oncology ·Aristotelis Bamias, Eleni Efstathiou, Lia A. Moulopoulos, Dimitra Gika, George Hamilos, Belogolovskij, I. Gilpin, Efstathios Kastritis, George Bozas, Christos Papadimitriou, Meletios Α. Dimopoulos	2005	54
20	Extended Rituximab Therapy for Previously Untreated Patients with Waldenström's Macroglobulinemia Clinical Lymphoma ·Meletios Α. Dimopoulos, Constantinos Zervas, Athanasios Zomas, George Hamilos, Dimitra Gika, Eleni Efstathiou, Panayiotis Panayiotidis, Elina Vervessou, Nikolaos Anagnostopoulos, John Christakis	2002	56

About Eleni Efstathiou

Eleni Efstathiou is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 203 papers that have together received 7.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (137 papers), Radiopharmaceutical Chemistry and Applications (53 papers), Cancer, Lipids, and Metabolism (34 papers), Prostate Cancer Diagnosis and Treatment (29 papers), PARP inhibition in cancer therapy (19 papers), Multiple Myeloma Research and Treatments (17 papers), Hormonal and reproductive studies (17 papers) and Cancer Treatment and Pharmacology (15 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.7k citations), Cancer Research (1.7k citations), Oncology (2.4k citations), Endocrinology, Diabetes and Metabolism (913 citations) and Radiology, Nuclear Medicine and Imaging (1.3k citations). Eleni Efstathiou has collaborated with scholars based in United States, Greece and Canada. Frequent co-authors include Christopher J. Logothetis, Meletios Α. Dimopoulos, Patricia Troncoso, Charles L. Sawyers, Sumit K. Subudhi, Anh Hoang, Howard I. Scher, Vassiliki Tzelepi, Μαρία Κάρλου and Karim Fizazi. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Urology, Clinical Cancer Research and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact